Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Vericel Corp (VCEL)
Standardized SEC financial data for Vericel Corp — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000887359 · NASDAQ · Biological Products, (No Diagnostic Substances).
Gross margin
74.4%
Operating margin
4.0%
Net margin
6.0%
Revenue growth (YoY)
16.4%
Return on equity
4.7%
ROIC
4.1%
Free cash flow
$24.7M
Debt / equity
0.00×
Ratios for fiscal year 2025, standardized from SEC filings.